Besondere Veranstaltungen 66
Breakthroughs and Debates
Mi, 27. 11. 2013
|
08.30– 10.00 Uhr
|
Saal 2
E
U
D
Breakthroughs in psychiatry: depression –
overcoming roadblocks in the development of truly
novel antidepressant strategies by research
Vorsitz:
Thomas E. Schläpfer, Bonn
Rainer Rupprecht, Regensburg
An update on recent efforts in novel treatment development
Alan F. Schatzberg, Stanford (USA)
Neurotarget structures that emerge from genetic and genomic
research
Florian Holsboer, München
Mi, 27. 11. 2013
|
12.15– 13.45 Uhr
|
Saal 2
E
U
D
Presidential Debate: new psychiatric
classifications – who is served, who is disserved?
Vorsitz:
Wolfgang Maier, Bonn
Andreas Heinz, Berlin
Better safe than sorry
Allen J. Frances, Coronado (USA)
The DSM-5 debates: much to do about nothing
Alan F. Schatzberg, Stanford (USA)
Fr, 29. 11. 2013
|
13.30– 15.00 Uhr
|
Saal 3
E
U
D
Presidential Debate: arising questions on an-
tidepressant therapy
Vorsitz:
Eckart Rüther, Feldafing
Thomas E. Schläpfer, Bonn
Antidepressants: are the benefits worth the risks?
Irving Kirsch, Hull (Vereinigtes Königreich)
Pharmacological treatment of depression: a remarkable
success story
Elias Eriksson, Gothenburg (Schweden)
Antidepressants: clinical problems and research realities
David Healy, Cardiff (Vereinigtes Königreich)
The important role of antidepressants in the treatment of
depression: research problems
Hans-Jürgen Möller, München
